Gene: MSLN ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 10232
Gene Symbol: MSLN
MSLN 		0.060 AlteredExpression disease BEFREE Here, we show that mesothelin is overexpressed in human triple-negative breast cancer cells and can be targeted by CAR T cells. 30523370 2019
Entrez Id: 10232
Gene Symbol: MSLN
MSLN 		0.060 Biomarker disease BEFREE A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer. 31354732 2019
Entrez Id: 10232
Gene Symbol: MSLN
MSLN 		0.060 Biomarker disease BEFREE Preclinical Evaluation of Mesothelin-Specific Ligands for SPECT Imaging of Triple-Negative Breast Cancer. 29572256 2018
Entrez Id: 10232
Gene Symbol: MSLN
MSLN 		0.060 Biomarker disease BEFREE Subset analysis in breast cancer showed MSLN amplification rates of 28% in triple-negative breast cancer (TNBC) and 33% in basal-like breast cancer. 26172299 2015
Entrez Id: 10232
Gene Symbol: MSLN
MSLN 		0.060 Biomarker disease BEFREE As there is no existing targeted therapy for TNBC, mesothelin may be a promising drug target for TNBC. 25193277 2014
Entrez Id: 10232
Gene Symbol: MSLN
MSLN 		0.060 Biomarker disease BEFREE Our results suggest that mesothelin has promise as a novel immunotherapy target for TNBC for which effective targeted therapy is lacking to date. 22418702 2012